Reserpine, an older medication originally used for managing hypertension, creates a competitive blockage of the transport of monoamine into presynaptic storage vesicles by interacting with vesicular monoamine transporter type 2 (VMAT2) as an internal monoamine. This evidence concerns the gene SLC18A2 and hypertensive disorder.